CervoMed Inc. Repayments of Related Party Debt
CervoMed Inc. (CRVO) reported Repayments of Related Party Debt of $0 for the 3-month period ending 2013-03-31, per its 10-Q/A filed 2013-05-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2013-05-20
- CervoMed Inc. repayments of related party debt for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. repayments of related party debt for the quarter ending 2012-03-31 was $71.00K.
- CervoMed Inc. repayments of related party debt for the quarter ending 2011-12-31 was $8.11K.
- CervoMed Inc. repayments of related party debt for the quarter ending 2011-09-30 was $162.60K, a 144.62% increase year-over-year.
- CervoMed Inc. repayments of related party debt for fiscal 2012 was -$27.20K, a 104.45% decline from fiscal 2011.
- CervoMed Inc. repayments of related party debt for fiscal 2011 was $611.78K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2013-03-31 | $0.00 10-Q/A · filed 2013-05-20 | |||
| 2012-12-31 | -$27.20K 10-K/A · filed 2013-04-24 | |||
| 2012-03-31 | $71.00K 10-Q/A · filed 2013-05-20 | $79.11K derived: sum of 2 quarters · filed 2013-05-20 | $241.71K derived: sum of 3 quarters · filed 2013-05-20 | |
| 2011-12-31 | $8.11K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | $170.71K derived: sum of 2 quarters · filed 2013-04-24 | $611.78K 10-K/A · filed 2013-04-24 | |
| 2011-09-30 | $162.60K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $603.67K 10-Q · filed 2012-11-19 | ||
| 2011-06-30 | $441.07K 10-Q/A · filed 2012-09-07 | |||
| 2010-09-30 | $66.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $221.94K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $155.47K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |